For decades, statins have been prescribed to tens of millions of Americans to lower cholesterol and ward off heart disease. Today, about one in three adults take them.
However, a 2024 study published in Cell Metabolism suggests these drugs may quietly disrupt another part of the body’s metabolism. Patients on atorvastatin, one of the most common statins, saw their levels of GLP-1—the hormone mimicked by Ozempic and other weight-loss drugs—drop by nearly half.
